Am. J. Respir. Crit. Care Med., Volume 162, Number 5, November 2000, 1823-1827

Muscle Size and Cardiorespiratory Response to Exercise in Cystic Fibrosis

CHUANPIT MOSER, PORNCHAI TIRAKITSOONTORN, ELIEZER NUSSBAUM, ROBERT NEWCOMB, and DAN M. COOPER

Department of Pediatrics, University of California Irvine Medical Center, Irvine; and Division of Pediatric Pulmonology, Miller Children's at Long Beach Memorial Medical Center, Long Beach, California

The mechanism responsible for diminished exercise performance in cystic fibrosis (CF) is not clear. We hypothesized that reduced muscle size, rather than an intrinsic muscle defect, was the primary factor in such diminished exercise performance. Twenty-two subjects with CF (14 females and eight males, aged 6.5 to 17.7 yr, with FEV₁ of 46% to 111% predicted) participated in a study of this hypothesis, and were compared with healthy children tested in the same laboratory. Muscle size was estimated from midthigh muscle cross-sectional area (CSA) obtained by magnetic resonance imaging, and fitness was determined by progressive cycle ergometer exercise testing with breath-by-breath measurements of gas exchange. Peak oxygen consumption ( O₂) was reduced in CF subjects (956 ± 81 [mean ± SEM] ml/min, as compared with 1,473 ± 54 ml/min in controls; p < 0.00001). Surprisingly, CF subjects had a lower peak O₂ per CSA (mean for CF subjects 70 ± 3% predicted, p < 0.0001) than did controls, whereas muscle CSA in CF subjects was not significantly smaller than in controls. The scaling parameters of peak O₂ and muscle CSA did not differ significantly between healthy controls (0.80 ± 0.16) and CF subjects (1.03 ± 0.12). Indexes of aerobic function that are less effort-dependent than peak O₂ were also lower in the CF subjects (e.g., the slope of O₂ versus work rate [WR] ( O₂/WR) was 68 ± 2% predicted; p < 0.005). The study data did not support the initial hypothesis, and suggest a muscle-related abnormality in oxygen metabolism in patients with CF.

This article has been cited by other articles:

				V. Dufresne, C. Knoop, A. Van Muylem, A. Malfroot, M. Lamotte, C. Opdekamp, G. Deboeck, M. Cassart, B. Stallenberg, G. Casimir, et al. Effect of Systemic Inflammation on Inspiratory and Limb Muscle Strength and Bulk in Cystic Fibrosis Am. J. Respir. Crit. Care Med., July 15, 2009; 180(2): 153 - 158. [Abstract] [Full Text] [PDF]

				T. Troosters, D. Langer, B. Vrijsen, J. Segers, K. Wouters, W. Janssens, R. Gosselink, M. Decramer, and L. Dupont Skeletal muscle weakness, exercise tolerance and physical activity in adults with cystic fibrosis Eur. Respir. J., January 1, 2009; 33(1): 99 - 106. [Abstract] [Full Text] [PDF]

				D. J. Serisier, A. D. Coates, and S. D. Bowler Effect of Albuterol on Maximal Exercise Capacity in Cystic Fibrosis Chest, April 1, 2007; 131(4): 1181 - 1187. [Abstract] [Full Text] [PDF]

				P. Palange, S. A. Ward, K-H. Carlsen, R. Casaburi, C. G. Gallagher, R. Gosselink, D. E. O'Donnell, L. Puente-Maestu, A. M. Schols, S. Singh, et al. Recommendations on the use of exercise testing in clinical practice Eur. Respir. J., January 1, 2007; 29(1): 185 - 209. [Abstract] [Full Text] [PDF]

				J. D. Dodd, S. C. Barry, R. B. M. Barry, C. G. Gallagher, S. J. Skehan, and J. B. Masterson Thin-Section CT in Patients with Cystic Fibrosis: Correlation with Peak Exercise Capacity and Body Mass Index. Radiology, July 1, 2006; 240(1): 236 - 245. [Abstract] [Full Text] [PDF]

				E. J. L. E. Vrijlandt, J. Gerritsen, H. M. Boezen, R. G. Grevink, and E. J. Duiverman Lung Function and Exercise Capacity in Young Adults Born Prematurely Am. J. Respir. Crit. Care Med., April 15, 2006; 173(8): 890 - 896. [Abstract] [Full Text] [PDF]

				M E Dodd and S A Prasad Physiotherapy management of cystic fibrosis Chronic Respiratory Disease, July 1, 2005; 2(3): 139 - 149. [Abstract] [PDF]

				A. J. Moorcroft, M. E. Dodd, J. Morris, and A. K. Webb Symptoms, lactate and exercise limitation at peak cycle ergometry in adults with cystic fibrosis Eur. Respir. J., June 1, 2005; 25(6): 1050 - 1056. [Abstract] [Full Text] [PDF]

				C Pinet, P Scillia, M Cassart, M Lamotte, C Knoop, C Melot, and M Estenne Preferential reduction of quadriceps over respiratory muscle strength and bulk after lung transplantation for cystic fibrosis Thorax, September 1, 2004; 59(9): 783 - 789. [Abstract] [Full Text] [PDF]

				H. C. Selvadurai, J. Allen, T. Sachinwalla, J. Macauley, C. J. Blimkie, and P. P. Van Asperen Muscle Function and Resting Energy Expenditure in Female Athletes with Cystic Fibrosis Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1476 - 1480. [Abstract] [Full Text] [PDF]

				S. C. Barry and C. G. Gallagher Corticosteroids and skeletal muscle function in cystic fibrosis J Appl Physiol, October 1, 2003; 95(4): 1379 - 1384. [Abstract] [Full Text] [PDF]

				ATS/ACCP Statement on Cardiopulmonary Exercise Testing Am. J. Respir. Crit. Care Med., January 15, 2003; 167(2): 211 - 277. [Full Text] [PDF]

				K. G. Tantisira, D. M. Systrom, and L. C. Ginns An Elevated Breathing Reserve Index at the Lactate Threshold Is a Predictor of Mortality in Patients with Cystic Fibrosis Awaiting Lung Transplantation Am. J. Respir. Crit. Care Med., June 15, 2002; 165(12): 1629 - 1633. [Abstract] [Full Text] [PDF]

				M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2000 Am. J. Respir. Crit. Care Med., November 1, 2001; 164(9): 1581 - 1594. [Full Text] [PDF]

				P. TIRAKITSOONTORN, E. NUSSBAUM, C. MOSER, M. HILL, and D. M. COOPER Fitness, Acute Exercise, and Anabolic and Catabolic Mediators in Cystic Fibrosis Am. J. Respir. Crit. Care Med., October 15, 2001; 164(8): 1432 - 1437. [Abstract] [Full Text] [PDF]